For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
UPLOAD: Pharmac's response to review
+News
UPLOAD: Pharmac's response to review
Friday 3 March 2023, 02:12 PM

Benefits of medicines must be shared more equitably across communities – especially Māori and Pacific communities and people living with disabilities
UPLOAD: In which we watch out for documents of interest to readers
Pharmac has today released its final response to the Pharmac Review, an independent review of the medicines purchasing agency.
A review panel commi
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.